Systemic autoimmune diseases are frequently associated with clustering of high titer autoantibody responses towards nuclear self-antigens. Little is known, however, about the extent of immune tolerance to the target nuclear antigens or the events leading to the complex autoantibody responses that are characteristic of systemic autoimmunity. To address these issues, we have examined the mouse immune response to La autoantigen (mLa) and the homologous human La antigen (hLa), which are components of the La(SS-B)/Ro(SS-A) ribonucleoprotein (RNP) complex targeted in systemic lupus erythematosus and primary Sj6gren's syndrome. The findings reveal the presence of hierarchical T cell tolerance involving multiple autodeterminants within the La autoantigen expressed by normal H-2 k and H-2 a mice. At one end of this spectrum, there was no detectable T or B cell autoimmunity observed in mice that were immunized with the immunodominant mLa28v 301 determinant, which differed by a single residue in its core sequence from the homologous but highly immunogenic human La288-302 determinant. Interestingly, the mLa287_301 peptide acted as an altered pepude ligand that specifically antagonized the activation of an hLa288_302-specific T cell hybridoma. In contrast to the tolerogenic mLa287_301 determinant, a range of autoimmune potential was identified among poorly tolerizing, subdominant self-peptides present within mouse La autoantigen. Notably, immunization of normal mice with the autologous subdominant La25_44 and La106_12 ~ determinants resulted in hmited or no detectable autoantibody response. In contrast, immunization with the subdominant mouse La13_30 determinant induced a proliferative T cell response associated with the appearance of specific autoantibodies recognizing multiple intrastructural (La) and intermolecular components (Ro) of the murine La/Ro RNP. The findings suggest how diversified autoimmunity might follow initiation of immunity to simple peptide mimics of poorly tolerogenic determinants that are present within ubiquitous self-antigens.
A key feature of many systemic autoimrnune diseases is the presence of high titer autoantibodies that recognize ubiquitously expressed nuclear or cytoplasmic self-antigens. These autoantibodies are relatively disease specific and often recognize multiple components of discrete subcellular particles (1) . For instance, autoantibodies that recognize nucleosomes, double-stranded DNA, and small nuclear ribonucleoproteins (snRNPs) 1 are characteristic of SLE, whereas antibodies that recognize components of the Ro (SS-A)/La (SS-B) 1Abbreviations used in this paper: aa, amino acid; GST, glutathlone S-transferase; 6xHls, 6x-hlsudme; HEL, hen egg lysozyme; hLa, human La antigen; LIA, I-Ak-transfected L cells; mLa, mouse La anUgen; PPD, purified protein denvauve. SI, snmulanon index; SnRNP, small nuclear ribonucleoprotems.
RNP are most commonly associated with primary Sj6gren's syndrome. Clustering of autoantibody responses probably reflects the physical association of the various target structures within distinct subcellular particles (1) (2) (3) . This notion is supported by experiments that show spreading of autoimmunity towards the different components of the Ulsn RNP (1, 4, 5) and the Ro/La RNP (6) after initiation of immunity to a single component of either complex.
We have previously shown that molecular spreading of immunity to the Ro/La RNP complex can be induced in normal mice by immunization with a single 107-amino acid (aa) fragment of the autologous La polypeptide (6) . These observations suggest that immune tolerance to nuclear self-antigens may be absent or incomplete, suggesting a degree of immune ignorance even in normal individuals.
Under these circumstances, spreading of autoimmunity may be naturally triggered by the initiation ofT helper immunity. Incomplete self-tolerance to sequestered self-antigen is described in some models of tissue-specific autoimmunity where nontolerogenic cryptic peptides are believed to play an important role in driving autoreactive T cells and antibody diversification (7) (8) (9) (10) . There is also some evidence that nontolerogenic determinants exist in ubiquitously distributed self-components (11) (12) (13) (14) (15) (16) including nuclear/cytoplasmic antigens targeted in systemic auto~mmunity (1, 4, 17, 18) . However, the precise extent to which the helper T cell compartment is tolerized to nuclear/cytoplasrmc antigens is not known, and the general nature of the selfdeterminants recognized by T helper cells in systemic autoimmunity is unclear.
We now show that healthy normal mice are tolerant to immunodominant T helper epltopes that are present within the La polypeptide of the La/Ro P,.NP. Nonetheless, T cells from the same mice can react to subdominant or cryptic determinants of La protein after autoimmunization. Moreover, our data demonstrate that experimental autoimmunity involving multiple intrastructural and intermolecular components of the Ro/La RNP complex can be induced in normal mice that have been immunized with a single subdominant or cryptic peptide derived from the La protein. These observations reveal how autoimmunity to a simple peptide determinant can lead to complex autoantibody patterns through intra-and intermolecular spreading. In addition, the findings suggest how limited molecular mimicry of a single antigenic region of a ubiquitous autoantigen might initiate spreading of systemic autoimmune responses through activation of poorly tolerized autoreactive T cells.
Materials and Methods
Protein Antigens. Recombinant mouse La (mLa), human La (hLa), human R.o 60 (htLo 60), mouse Ro 52 (mRo 52), and hen egg lysozyme (HEL) were produced in bactena as 6-hisndine (6xH1s) fusmn proteins expressed in Escherichia coli from the vector pQE (QIAGEN, Inc., Chatsworth, CA). Alternatively, these proteins were expressed as glutathlone S-transferase (GST) fusion proteins from the pGEX-2T bacterial plasmid vector (Amrad, Melbourne, Austraha). 6xHis-hLa was also expressed in insect cells infected with fe~combinant baculovirus, and was kindly supphed by Dr. Nell Cook (Ehas, Freiburg, Germany). Subfragments ofmLa and hLa were expressed as GST fusion proteins as described previously (19, 20) . Bacterial recombinant proteins were purified by either metal chelate affinity chromatography (Ni-NTA affinity chromatography) (21) or glutathione affinity chromatography (22) . Recombinant proteins were passed through an endotoxin column (Pierce, Chemical Co., Rockford, IL) to remove bacterial endotoxins potentially contaminating the preparations. Native and recombinant La antigen is known to be sensitive to proteolysis (23, 24) , and mass spectrometric analysis of purified recombinant 6xHls-La antigens indicated that the majority of bactenal recombinant La proteins possessed a molecular mass of ,-43 kD instead of the predicted 48 kD. This discrepancy in molecular mass is presumed to reflect bacterial proteolysis associated with protease-sensltive PEST regions of La (23) (24) (25) (26) . When 6xHis-hLa was produced in the baculovirus expression system, the resultant La protein was full length, as judged by its mol mass of`"48 kD after SDS-PAGE. Accordingly, baculovirus recombinant La protein was used in several immunizations to complete the T cell epltope mapping of the munne immune response to hLa.
Peptides. For initial screening of peptide specificity of lymph node T cells, a set of 155 overlapping 15-mer peptides ofhLa was synthesized by the multlpin synthesis system (Chiron Mimotopes, Clayton, Australia; 27) using optimized F-moc-based chemistry (28, 29) so that peptides could be cleaved from the pins. Peptides were dissolved in DMSO at ~1 mM concentration. Pepndes spanned the complete length of the La molecule sequentially shifting by 2 or 3 amino acids, giving a 13-12-aa overlap of adjacent peptides. The peptIdes hLa 288-302, mLa 287-301, 13-30, 25-44, 106-129, and HEL 46-61 were synthesized on an automated peptide synthesizer (model 431A; Applied Blosystems, Inc., Foster City, CA) using both t-Boc-and F-moc-based chemistries, and were subsequently purified by reverse phase HPLC. The peptides were analyzed and their masses were confirmed by electrospray 1onisation mass spectrometry using a triple quadrupole mass spectrometer (AP III; Perkin Elmer-Sciex, Ontario, Canada). The mLa amino acid sequence contains a single amino acid deletion at the position corresponding to hLa residue 217 and a 16-aa insertion after position 332, which changes the numbering of some mLa peptides relative to their hLa equivalent (30) .
Immunization. 6-8-wk-old female A/J (H-2 ~) and CBA/CaH (H-2 k) mice were purchased from the Animal Resource Centre (Perth, Australia) and maintained in the animal house at Flinders Medical Centre (Adelaide, Australia).
For in vitro T cell proliferation assays mice were ~mmumzed subcutaneously in the tad base and in one hind footpad with 20 tiM La peptides or 100 txg either 6xHis-hLa, 6xHls-mLa fusion proterns, or baculovirus hLa protein in each site. The antigens were emulsified 1:1 in CFA containing Mycobacterium tuberculosis strain H37R_a (Difco Laboratories, Detroit, MI). For analysis of T cell reactivity, pophteal and inguinal lymph nodes were removed and recovered cells were pooled 9-10 d after the initial challenge.
For assessment of antibody responses, mice were immunized subcutaneously m the tail base with 20 IxM La peptides or 100 txg 6xHls-La fusion proteins emulsified 1:1 in CFA. The mice were boosted twice at 10-d intervals with 10 tim pepndes or 50 p,g fusion proteins emulsified 1:1 in IFA, and 3-4 d after, the last boost animals were bled.
Lymph Node Proliferation Assays. 9-10 d after immunization, unfractionated pophteal and inguinal lymph node cells were pooled and processed as a single-cell suspension and cultured at 5 × l0 s cells/well in flat-bottom 96 well-plates in HL-1 serumfree medium (Hycore Biomedical Inc., Irvine, CA) supplemented with 2 mM glutamine and 5 × 10 s M 2-ME and 5 tim ofa hLa pepnde. For epitope screening, pairs of consecutive pepndes were added to the same wells and tested m triplicate. T cell proliferation was measured by the addition of 0.5 IxCi of [JH]thymldme (ICN, Costa Mesa, Irvme, CA) for the last 18 h of 96-h cultures, and thymldine incorporation was measured using a multldetector direct beta counter system (Matrix 9600; Packard Instrument Co., Menden, CT). The stimulation index (SI) was calculated as the ratio of cpm measured in the presence vs. absence of specific antigen.
In some experiments, before setting up the proliferation assay, lymph node T cells were purified by passing the cell suspensions through a nylon wool column (31) . The T-enr, ched lymph node cells (2 × 10S/well) were then cultured with irradiated syngenelc spleen cells (2,000 rads; 4 × 10S/well) in triphcate assays in the presence of either protein antigens, pepndes, purified protein derivative (PPD; Commonwealth Serum Laboratories, Melbourne, Australia), Con A or medium alone. These assays were performed as for unfracnonated LN cells, except that cells were cultured in complete DMEM medium (DMEM medium supplemented with 10% FCS, 2 mM glutarmne, 1 mM Hepes, 5 × 10 s M 2-ME, 1 mM pyruvate, and 1 mM nonessential amino acids).
Generation of T Cell Hybridomas.
The I-Ak-restncted, hLa-speclfic T hybndoma 11B1 was generated by lmmumzing A/J mice with 6xHls-hLa (100 btg) emulsified m CFA and fusing the activated T blasts (32) from the draining lymph node cells to the TCR-neganve, HGPR.T-negative AKR, thymoma line BW5147 (32, 33) .
For preparation ofT cell blasts, the immune LN cells (4 × lffV ml per well) were restlmulated for 4 d in 24-well plates (Costar, Cambridge, MA) containing 6xHls-hLa (100 Izg/ml) in 2 ml of complete ILPMI 1640 medium (supplemented with 10% FCS, 2 mM glutanfine, 1 mM Hepes, and 5 × 10 -5 M 2-ME). Viable cells enriched for T blasts were isolated on Flcoll-Hypaque gradients, and 5 × 107 cells were fused with BW5147 (107 cells) in 42% polyethylene glycol (tool wt = 1,500; BDH Chemicals, Poole, England) and 15% DMSO. Cells (1 ml) were then plated in 24-well plates (105 cells/well) with A/J splenic feeder cells (2 × 10 s cells/well) in a total volume of 2 ml complete RPMI 1640. HAT medium (complete RPMI containing 1.1 × 10 4 M hypoxanthine, 1.6 × 10 -5 M thymldine, and 4 × 10 v M ammopterin) and the medium (complete RPMI-HAT) was changed every 3 d. Hybrid growth was first observed at ~10 d after fusion. After "~3 wks, cells were transferred to new plates and gradually adapted to medium containing HT (complete lkPMI plus 1.1 × 10 -4 M hypoxanthine and 1.6 × 10 -~ M thymidine). Hybrids were screened for specificity and then cloned by limiting dilution. The representative T cell hybridoma 11B 1 was studied in further detail. T Cell Antagonism Aassays. For assays of T cell antagonism, LIA (10S/well) or spleen cells from A/J mice (2 × 10S/well) were incubated with a nonsaturating concentration of hLa2ss_302 peptide (100 riM) or 6xHis-hLa protein (4 p~M) for 2 h at 37°C. The free antigen was removed and APC were washed once before further culture with graded amounts of either mLa287_3m peptide or 6xHls-mLa protein. After 2 h, cells were washed once before the addition of the hLa-specific T cell hybridoma 11B1 (105 cells/ well). The supernatants were harvested 24 h later and were assayed in tnphcate for IL-2 content by [3H]thymMme incorporation of CTLL.
T Cell Hybridoma Antigen Presentation
Western Blotting. P,,ecombmant anngens and control proteins were separated through 12.5% SDS-PAGE and electrotransferred to Hybond C extra nitrocellulose membranes (Amersham, Buckinghamshlre, UK). The membranes were blocked with 3% skim milk in PBS (wt/vol) for 1 h and then incubated for 1 h with the relevant sera (1:250 or 1:500 dilunon). After 3 × 10 min washes in 3% skim milk In PBS, the membranes were incubated for another 1 h with a 1:1,000 dilunon of horseradish peroxidase-conjugated goat anti-mouse IgG (Sigma Immunochemicals, St. Lores, MO). After a further three washes in buffer, the bound antibodies were detected by enhanced chemiluminescence (Amersham, Intemanonal, Buckinghamshire, UK).
Antibody Estimations by ELISA. Recombinant protein was coated on to Maxlsorp mlcronter plates (Nunc, R.oskilde, Denmark) by incubating 200 ~1 of protein at 5 btg/ml m 0.03 M carbonate buffer at pH 9.6 overnight at 4°C. The plates were blocked for 1 h at 37°C and incubated with mouse serum diluted m PBS buffer containing 0.2% BSA and 0.05% Tween 20 for 2 h at 37°C. After washing in 0.05% Tween 20 in PBS, the plates were incubated with an alkaline phosphatase-conjugated goat ann-mouse IgG (Pierce) for another 2 h. Bound antibodies were detected by hydrolysis of the p-nitrophenyl phosphate substrate, and the developed color was measured at OD 405 nm.
Results

Immunization u,ith Recombinant La Protein blduces Autoantibodies and Proliferative T Cell Responses to both hLa and mLa
Antigen in Normal Mice. We have previously shown that immunization of normal healthy mice with recombinant mLa or hLa protein induced isotype-switched autoantibody production, suggesting T helper dependence of the immune response (data not shown and reference 6). The autoimmune response towards La is also associated with the development of autoantibodies to the Ro 60-kD antigen occurring 14-20 d after immunization (6) . Immunization with either mLa or hLa induced ann-La autoantibodies, indicating that T helper determinants were present in La protelns from both species. Moreover, the hLa and mLa amino acid sequences are 77% identical (30) , suggesting that shared T epitopes might exist in these homologous proteins. However, the magnitude of the induced autoantibody response was consistently greater in mice that were challenged with hLa compared to those challenged with mLa (6), implying the presence of additional T helper determinants (xenogeneic epitopes) in hLa and providing enhanced T help for the B cell response. To confirm that immunity to the La proteins was associated with specific T cell responses, normal mice were immunized with recombinant hLa protein, and 9 d later, responding lymph node T cells were examined for their specificity in vitro. Lymph node T cells from immunized mice specifically responded to 6xHis-hLa and 6xHis-mLa, but not to 6xHis-DHFP,. or recombinant GST protein ( Fig. 1 A) . The observation that T cells responded to both mLa and hLa confirmed the presence of shared or cross-reactive T cell epltopes present within these antigens ( Fig. 1 A) . Multiple T cell epitopes were apparently present in hLa, since La subfragments containing GST-hLaA (hLa amino acids 1-107) and GST-hLaC (hLa amino acids 111-243) also stimulated hLa-primed lymph node T cells. (Fig. 1  A) . The presence of T cell autoepitopes in mLa was further verified by immunizing mice with 6xHis-mLa and examining the response of lymph node T cells to either 6xHis- mLa, 6xHis-hLa, GST-mLa, or GST-hLa proteins 9 d later (Fig.i , B and C). The results confirmed the presence ofautoreactive T cells that responded in a dose-dependent manner to the 6xHis and GST forms of recombinant mLa protein ( Fig. 1 , B and C). Notably, in mice immunized with mLa, the in vitro T cell response upon subsequent challenge with mLa was sometimes ( Fig. 1 , B and C) but not always (data not shown) greater than the response observed after rechallenge with hLa. This observation suggested that mLa may also contain unique autodeterminants not found in hLa and which might contribute to the experimental autoimmunity induced by immunizing with mLa. It was also noted that responding T cells reacted to the GST-La fusion proteins with a dose dependence different from that observed for the 6xHis-La proteins implying that the covalent presence of the GST domain (mol mass "°26 KD) may alter the efficiency with which GST-La proteins are processed.
The Specificity of the Murine T Cell Response to hLa Includes Xeno-andAutodeterminams.
In nmnerous experiments, we noticed that the T cell response to hLa immunogen was The result of one expenment after challenge with baculovlrus hLa is shown here. Peptldes corresponding to residues 1-294 contained a 3-aa shlR or 12-aa overlap (i.e., 1-15, 4-18, etc.). Peptides corresponding to residues 282-408 contained a 2-aa shift or 13 aa overlap (1.e., 282-296, 284-298, etc.). For epitope screening, peptides were pooled in pairs with the posmon of the anaino temnnus of the first peptlde of every second pair shown on the x-axis (i.e., 1 corresponds to 1-15 and 4-18; 13 corresponds to 13-27 and 16-30, etc.) . Tnphcate LN cell cultures (5 X 10S/well) were cultured in HL-1 mechum (Hycore) contaimng 5 poM (final) of each of the relevant peptldes Proliferative data are shown as the SI The average SI of control non-La peptldes was ~<l. An SI />2 was considered posmve ifa clustered response (/>2 adjacent pepude pairs) occurred in one or more expenment. The amino acid residues of positive responses obtained in all expenments are shown above the relevant pepndes. The dashed hne corresponds to an SI of 2 A single ammo acid deletion in the mLa sequence corresponding to hLa residue 217 and a 16-residue insertion in mLa after position 332 alters the numbenng between equivalent mLa and hLa peptides after these posinons (30) . *AUTO, determinant of hLa where the same sequence is present in mLa; XENO, determinant sequences that differ between hLa and mLa. The hLa~,t_84 and hLae~u_30a pepndes were defined as immunodommant, based on the magnitude (SI generally i>6) and frequency of their reacnvtty. Although hLa13_3, was reactive ~n six to eight experiments, the magnitude of these responses was consistently margnnal (SI ¢'-'2), so this determinant was defined as subdommant. Positive proliferative T cell responses are defined as an SI i>2 present in two or more adjacent pairs ofpepndes and occumng m one or more experiment consistently higher, and that it occurred at lower concentrations of hLa protein than the analogous responses that occur after immunization with mLa (data not shown). This observation was consistent with the differential pattern of autoantibody production after immunizanon with the two forms of La protein (hLa >mLa; 6). These findings suggested that in addition to determinants shared between hLa and mLa, xenogeneic T cell determinants present in hLa antigen might render this protein more immunogenic in m~ce than autologous mLa. Moreover, we reasoned that immunodominant regions of La may be easily revealed in hLa, but may be potentially tolerogenic and therefore invisible in mLa (12) . To test this hypothes~s, we mapped the mouse T cell response to hLa antigen. Lymph node T cells were isolated 9 d after immunization with 6xHis-hLa and tested for reactivity with a panel of 155 overlapping peptides spanning the complete hLa molecule. Peptides were pooled as pairs of t5 mers overlapping by two or three residues w~th the next peptide. A summary of these experi-ments is shown in Table 1 , and the actual data from one such experiment is given in Fig. 2 . Two determinants, hLa288_31,2 (core amino acids 289-299) and hLa61_84 (core amino acids 67-78), dominated the T cell response to the hLa antigen. Maximal proliferation was always observed to the hLa288_302 peptide, which was stimulatory in eight out of eight experiments, while hLac, t_84 stimulated strongly in six out of eight experiments. The core amino acid sequence of both epitopes revealed that they were xenogeneic determinants differing from the homologous mLa determinants by a single residue (hLa295Q---)mLa294L) in the case ofhLa2~9_299 (mouse homologue = mLa288_298) and two residues (hLa70E-+mLa70Q and hLa78E--->mLa78K) in the case of La67_78 (mouse homologue = mLa67_78; Table 1 ). At least five other xenogeneic hLa determinants were identified as defined by clustering of the relevant T cell response to involve two or more pairs of overlapping peptides with a SI i>2 in one or more experiment. However, a feature of the responses to these additional xenogeneic determinants and mLa2,v_3.1 peptides to I-A k was demonstrated in a competitive inhibition assay (C) Thus, graded concentrations of the synthetic peptides hLa288 I0e (~) or mLaeu7 3< (D) were incubated with LIA APC m the presence of a nonsaturatmg concentranon of the HEL46_(, I peptlde (10 nM) for 18 h at 37°C. After washing out the free peptides, the competmve displacement of HEL4e , ~, 1 was assayed by measunng Inhibition of IL-2 production by the I-Ak-restncted. HELa6_61-specific T hybndoma 3A9. Each point represents the mean value of mphcate assays, and the experiment was repeated three umes Functional presentation of mLa2u v 3~1 was revealed by demonstrating speofic antagonism of the 1 IB1 response to hLa2ss 3.2 by the mLa2sv_3,,1 detemunant after preloading APC with a nonsaturatmg amount of (D) synthetic hLa28 x 3.2 peptide (100 nM) for 2 h before the addition of graded amounts of rather mLae.7_~.l ([[]) or the irrelevant l-Ak-bmdmg peptide HEL4~ , ~,, (O). (E) APC were preloaded with a fixed, nonsaturating amount of 6xHls-hLa protein (4 bLM) for 2 h befbre the addmon of graded amounts of 6xHls-mLa protein ([1) or control protein HEL (O) APC were then incubated for another 2 h and subsequent activation of 11B 1 was measured as IL-2 production The maxmmm responses (1 ()()%) of 11 B 1 to the fixed amount of either hLa2~ ~ 3,2 (added to LIA APC) or 6xHls-hLa protein (added to splenic APC) were 5.500 and 6,2i,1 cpm, respecnvely Each point represents the mean value of tnphcate assays, and the entire assay was repeated three times. The dashed hnes in D and E represent the esmnated lCs0 values for mLa2s7 ~.l and 6xHis-mLa m thelr antagonism of the 11B1 T hybndoma response to the hLa2ss_~e determinant was the generally low level ofT cell stimulation (SI = 2-6) and the failure to stimulate T cells in every experiment, consistent with the determinants being either subdominant or facultanvely cryptic (35) .
In addition to these xenoresponses, significant T cell reactivity was identified towards three hLa peptide determinants containing identical amino acid sequences to the homologous peptide regions of mLa. These "autoepltopes" corresponded to peptides in common with hLa and mLa at amino acid residues 13-30 (reactivity in six out of eight experiments), 25-44 (reactivity in three out of eight experiments), and 106-129 (reactivity in four out of eight experiments). In the experiment shown in Fig. 2 , the La25_44 determinant did not stimulate hLa-primed T ceils. Indeed, each autodeterminant behaved as cryptic or subdominant epitopes in that they produced only low levels of T cell proliferation, and in some experiments, they were nonstimulatory. Taken together, these findings confirmed the suspicion that hLa and mLa protein contained shared, notionally autologous T cell epitopes in addition to xenogeneic hLa determinants recognized by the murlne immune system.
Efficient I-Ak-restricted Presentation of the hLa2a8_302 and mLa28~30, Determinants.
The dominant hLa determinant hLae88_3(, 2 contained a single species polymorphism within the core residues La289 299 when compared with the homologous sequence La288_298 present in mLa (note that mLa contains a single amino acid deletion at the position corresponding to hLa amino acid 217; see Table 1 ). This observation suggested that the immunodomlnance of hLa28~_3. 2 depended on its xenogeneic sequence, and that the equivalent determinant in mLa might be tolerogenic in normal mice. Therefore, we examined the clonal specificity ofT cells responding to the donfinant hLa288 3o2 determinant to eval-uate whether these T cells cross-reacted with the equivalent mLa peptide (non self-tolerant) or whether they were hLa specific (putatively self-tolerant). After immunization with hLa protein, CD4-positive T cell hybrid clones were generated from the responding lymph node cells and analyzed for their peptide specificity. One such hybridoma clone (11B1) gave a strong in vitro response to the hLa288_302 peptide, and the pattern of reactivity with four overlapping peptides spanning this region identified the minimal epitope as hLa289_299 (data not shown). This finding verified the presence of mouse T cells recognizing hLa288_302 in the bulk T cell responses shown in Fig. 2 .
Notably, 11B1 did not respond to the autologous mLa28 v 301 (or mLa288_29s) peptide, except at high peptide concentrations using the I-Ak-transfected L cell APC, (LIA; Fig. 3 A and data not shown). The T hybridoma 11B1 also secreted IL-2 in response to intact hLa, but not to mLa protein (Fig.  3 B) . The species specificity of 11B1 for hLa288_302 was observed with splenic APC and LIA (Fig. 3, A and/3 ). The nonresponsiveness of 11B1 to mLa287_301 was not the result of defective presentation or crypticlty of mLa2s7_301 for several reasons. First, mLa2s7 .m~ was able to bind I-A k with equivalent efficiency to hLa2as_302 based on the comparable ability of these two peptides to compete with the I-A krestricted recognition ofa HEL46 ~, 1 peptide (Fig. 3 C) . Second, the mLa287_301 peptide behaved as an altered peptide ligand (36, 37) for the T hybridoma 11B1. Altered peptide ligands characteristically contain a single amino acid substitution from the parent peptide and can block T cell responses even when present in concentrations too low to be explained by competitive displacement of the parent (agonist) peptlde (36, 37) . In the experiment shown in Fig. 3 D, APC were preloaded with a fixed concentration ofhLa28s_302 (100 nM), washed free of agonist peptide, and then incubated with increasing concentrations of mLa287_301 before assaying antigen presentation to 11B1. Specific antagonism of the 11B1 response occurred at a 50% inhibitory antagonist (mLa287_301)/agonist (hLa288_3(,2) ratio of~10 -~ (Fig. 3  D) . When the I-Ak-restricted determinant HEL46_61 was titered into the Ag presentation assay under the same conditions, there was no evidence of specific T hybridoma antagonism, and only modest competitive inhibition of the 11B1 response was observed at a higher concentration of HEL46_61 (Fig. 3 D) . Antagonism of the 11B1 response was also observed using the minimal determinants mLa288_298 and hLa289_299 as antagonist and agonist peptides (data not shown), indicating that the 11B1 response was dependent on position 294L-->295Q (mLa-+hLa). This observation confirms that the antagonist properties of mLa2u8 298 arise from this single amino acid substitution, creating an altered peptide hgand for the hybridoma 11B1. At high concentrations of mLa287_3m , some agonist activity was observed when using the L cell transfectants (Fig. 3 A) , which express higher levels of I-A k than splenic APC (data not shown).
The 1 1B1 response to intact hLa was also antagonized in the presence of very low ratios of intact mLa/hLa antigen (50% inhibitory antagonist/agonist ratio of 0.5-1 × 10-3), indicating efficient processing of the La autoantigen resulting in presentation of peptides containing the mta288_298 determinant (Fig. 3 E) . Under the same conditions where APC were prepulsed with a fixed stimulatory amount of intact 6xHis-hLa, titration of increasing amounts of HEL into the Ag presentation assay resulted in only modest competitive inhibition of the 11Bl response (Fig. 3 E) . Notably, HEL contains mutiple I-Ak-restricted determinants that are capable of competitive displacement of hLa2~8_302 (38) emphasizing the potent antagonist properties of the naturally presented mLa288__,g8 determinant derived from mLa protein.
Cellular mLa is probably not presented through an endogenous pathway because its nuclear localization and low abundance render it inaccessible to the endosomal class II antigen presentation pathway (39, 40) . Moreover, a human cell line expressing I-A k did not constitutively present the endogenous hLa288_302 determinant, but could present exogenous native and recombinant hLa antigen (data not shown). These observations are likely to explain why 11B1 responses to hLa are not constitutively antagonized by endogenous mLa antigen present in murine APC. As in the case ofmLa287_301 peptide (Fig. 3, A and D) , at high concentrations the intact mLa antigen (Fig. 3 E) showed some agonist activity by paradoxically stimulating the 11B1 hybridoma incubated with APC preloaded with a fixed amount of hLa288_302 peptide or hLa protein antigen. Agonism induced by high concentrations o f antagonist determinants is acknowledged in many systems where altered peptide hgands are recognized by the responding T cell (36, 37) . Taken together, these data confirmed that mLa287_3< was processed and presented by APC loaded with intact mLa antigen, and was readily recognized by specific T cells, even at low concentrations of exogenous antigen, consistent with this peptide being an immunodominant mLa determinant.
T Cell Tolerance to the Dominant mLa287_3o ! Determinant in Normal Mice. The presentation of the mLa2s7_30~ determinant after antigen processing and the immunodominance of the homologous hLa2ss_302 determinant suggested that the mLa28v_301 region might be highly tolerogenic in normal mice. To test whether this was the case, groups of normal H-2 a mice (I-A k) were immunized with either hLaess_302 or mLa287_301 in Freund's adjuvant, and draining lymph node T cells were tested for proliferative reactivity 9 d later. T cells from mice primed with the hLa288_302 determinant responded vigorously to this peptide (50% max response at "-'20 nM; Fig. 4 A) , and the response was recalled on the intact hLa antigen (Fig. 4 B) . In contrast, T cells from mice primed with mLa2s 7 3,1 proliferated poorly to the mLa287_3o 1 peptide, even at high concentrations (50% max response at ~1 raM; Fig. 4 A) , and failed to respond at all to the intact mLa antigen (Fig. 4 B) .
As shown in Fig. 3 , the lack of T cell reactivity to mLa287_301 was not caused by a failure to bind I-A k or by a lack of presentation of this determinant from intact antigen. However, it was possible that the mLa287 3,1 peptide might have induced autoreactive T helper cells that proliferated poorly despite providing functional cytokine support for specific autoantibody responses. Therefore, we also tested the sera of animals immunized with mLa287_30 t peptide for the development ofanti-La antibodies. Neither the rnLa287_31)l nor the hLae8s_302 peptldes provoked an autoantibody response under conditions where immunization with intact 6xHis-rnLa induced a significant antl-La response (Fig. 5 A) . Notably, immunization with hLa288_302 induces a vigorous proliferative T cell response (Fig. 4, A and/3 ) without inducing autoreactivity to endogenous murine La (Figs. 3  and 5 A) , again reflecting the lack of functional T cell cross-reactivity between mLa287_3m and hLa28s_3112 in the murine T cell responses. Presumably, the lack of autoantibody production despite efficient T immunity to hLa28s_302 reflects the absence of B epitopes in this peptide and the failure of reactive T helper cells to recognize the mouse homologue of this determinant. Therefore, we concluded that the T cell repertoire in normal mice was specifically tolerant of the mLa287_301 determinant, presumably because of its efficient presentation to the T cell compartment relative to other determinants. Hence, we inferred that the induction of autoimmunity to mouse La protein (Fig. 5 A and reference 6) was likely to depend on T helper cell responses that recognize nontolerogenic subdominant mLa determinants such as the mEal3_30 , mLa2s_44, and mLam6_12, ) peptides rather than immunodominant determinants within mLa.
Induction of T Cell bnmunity and a Divers~ed Anti-La/Ro R N P Autoantibody Response by a Nontolerogenic Subdominant Determinant ofmLa. To test whether the subdominant La determinants La13_30 , La25_44 and La106q29 could initiate anti-La autoantibodies, we immunized groups of normal mice with one or other of these peptides in Freund's adjuvant and boosted the response two to three times during a 4-5 wk period. Sera were then tested by ELISA for the presence of autoantibodies recognizing recombinant La protein. There was no detectable anti-La response after immunization with the mLa106q29 determinant; however, both the mLa2s_44 and mLa13_30 peptides induced a significant anti-La autoantibody response in the majority of immunized animals ( Fig.  5 /3 ). The pattern of responses to the three subdominant peptides suggested a hierarchy o f autoimmune potential among self-peptides (Fig. 5 B) , perhaps reflecting their intrinsic tolerogenicity or the nature o f T cell responses associated with individual peptides.
Immumsing antigens Immunismg anbgens after the last boost, mnchvmdual sera were pooled and tested at 1/100 (A), or were tested mdlwdually at 1/500 (B) for antHnLa annbody reacnwty by ELISA using 6xHls-mLa-coated mmcronter plates. The reacnwty of premlmune serum also is shown. The value shown for the 6xHls-mLa track m (/3) is denved from a 1/500 dfluuon of pooled sera from six unmune mice &fferent to those described above m A Intra-and intermolecular spreading of autoimmunity towards the different components of autologous subcellular particles has previously been described w h e n i m m u n i t y to a single component of the particle is triggered experimentally (1, 4, 6) . To determine whether similar autoantibody spreading could be initiated by immunity to a single subdominant La peptide, we further examined the specificity of the autoantlbody response to mLa13_3~, and mLa2s_44 by Western blot analysis. In A/J mice immumzed with ntLa25_44 , the autoantibody response was restricted to the La A subfragment containing the mL%5 44 peptide ofLa autoantigen (data not shown). By contrast, pooled sera from m~ce immunized and boosted with mLal3_30 specifically reacted with recombinant and mammalian sources of intact La antigen in immunoblots (Fig. 6, upper panel) . Moreover By contrast, absorption with recombinant GST protein had no significant effect on the reactivity of the pooled serum with La subfragments (data not shown). This finding confirms that reactivity of the i m m u n e sera with different regions of the La polypeptide was not caused by cross-reactive antibodies. In addition, i m m u n o b l o t reactivity of the i m m u n e sera was not observed with the control proteins 6xHis-DHFP,, 6xHis-HEL, or with other nuclear proteins such as Sm polypeptides k n o w n to be present in the rabbit thymus extract (Figs. 6 and 7) . A component of the anti-La response that develops after immunization with mLal3_30 is probably directed towards the La13_3a peptide itself since this peptide absorbs some of the antibodies directed towards the LaA subfragment that contains these residues (data not shown).
To determine whether intermolecular spreading of autoimmunity also follows immunization with mLa13_30 , pooled i m m u n e serum was examined for lmmunoblot reactivity with the R o (SS-A) autoantlgens (Fig. 7) . The R o 60-kD antigen is k n o w n to be associated with the La polypeptide in a snP.NP particle (42) , and autoantibodies to both R o 60-kD and R.o 52-kD antigens are strongly associated with anti-La antibodies in systemic autoimmunity (43) . Pooled sera from mice immunized with the La13_30 peptide reacted specifically with recombinant R o 52-kD antigen (Fig. 7) ; however, reactivity with recombinant Ro 60-kD antigen was equivocal and not observed in all experiments (data not shown). The titer ofanti-Ro 52-kD antibodies was significantly lower than that of the anti-La response (1/500 for anti-P,.o 52 and ~<1/3,000 for anti-La antibodies). Nonetheless, this reactivity was specific, since binding to control recombinant proteins (6xHis-DHFR and 6xHis-HEL) was not observed under the same conditions, (Fig. 7) . We conclude that immunization with the subdominant mLa13_30 peptide is sufficient to induce intramolecular spreading of autoimmunity to La autoantigen, as well as a low level of lntermolecular antibody spreading of the autoimmune response.
The Autoantibody Response to the mLa13_30 Determinant Is Associated u,ith an Autoreactive T Cell Response. Triggering of autoimmunity by immunization with subdominant peptides such as the mLal3_30 peptide was presumed to occur through the activation of nontolerized T helper cells that recognize this determinant. Therefore, we evaluated whether immunization with mLa~3_30 peptide induced specific autoreactive T cells. CBA/CaI-I mice were immunized with mEal3_30 peptide in adjuvant, and draining lymph node T cells were examined for antigen reactivity 9 d later. Immune T cells proliferated specifically in response to mLa13_30, but not control peptides mLa25 44, mLaes7_3,1, or HEL46_61 (Fig.  8 A) . These T cell responses were recalled in the presence of recombinant intact mLa, hLa, and mLaA subfragment (residues 1-107) but not the control protein 6xI-Iis-DHFtL (Fig. 8 B) . Similar results were obtained after immunization of A/J mice (data not shown). Hence, the spreading autolmmunity that follows immunization of normal H-2 k mice with the subdominant mLa 13_3. peptide is associated with specific T helper responses recalled on intact mLa antigen.
Discussion
Although La is ubiquitously expressed in the nucleus and cytoplasm of diverse cell types, there is little data about the extent of immune tolerance that develops to this or many other intracellular sequestered self-antigens in normal individuals. Indeed, establishing whether the immune system is actively tolerant to a given determinant within a selfantigen is experimentally difficult because of the many ways in which nonresponsiveness may occur and the need to examine the host immune response in the presence and absence of expression of the self antigen. In the experiments reported here, we have immunized mice with a surrogate self-antigen, vlz., the human La antigen that is 77% identical to mouse La (30) . This approach has allowed identification of an immunodommant determinant of human La (hLaess_302) and a homologous but tolerogenic epitope derived from endogenous mLa (mLa287_301). The evidence that this determinant is tolerogemc in mice is based on the lack of either T cell responses or autoantibodies after immunization of normal mice with the mLa287_3m pepude. The mLa determinant was efficiently presented after antigen presentation, as demonstrated by inhibition binding studies to I-A k and specific antagonism of the immunodomlnant hLa288_302 homologue by both intact mLa and the mLa2s 7 301 peptide that possessed properties of an altered peptide ligand for hLa288_302 recognition. Sercarz has cautioned that despite antigen presentation and immunodominance of a particular determinant in one species, comparable immunodominance cannot be assumed for homologous determinants across species (15) . Nonetheless, in this case, the hLa2a8_302 and mLa2~7_3,,1 determinants do appear to be equivalent in their antigen presentation and behave as immunodominant peptides in H-2 k and H-2 a mace.
The tolerogenicity of mLae87_3m indicates that endogenous La polypeptides are indeed processed and presented to host T cells, presumably by an exogenous pathway involving uptake and catabolism of La/Ro RNP particles. This putative turnover and antigen presentation of endogenous P.NPs clearly does not lead to autoimmunity under normal conditions. However, once autoreactive T cells have been primed towards poorly tolerogenic determinants within the La/P.o RNP, antigen presentation after the natural uptake of these RNPs appears to be potentially autmmmunogenic. In our experimental model, the poorly tolerogenic determinants are presumably subdominant or might behave as facultatively cryptic regions of the La molecule that are only presented under special circumstances. Regardless, humoral immunity to mLa is easily triggered experimentally and is associated with T cell responses to subdominant determinants. Although our assays have measured proliferative T cell responses, these responses are assocmted with functional T helper cells revealed by the isotype switching of associated autoantibody responses.
The autoreactive T cell response induced by the mLa13_30 subdominant peptide was recalled on intact La antigen, even though T cell responses to this and other subdominant mLa peptides were not evident in every experiment involving immunization with intact La protein. This pattern of autoreactiwty is distinct from the autoimmune T cell responses that recognize cryptic peptides of the snRNP D protein described by Bockenstedt et al. (4) . In that study, priming of T cells with peptides derived from snlLNPs resuited in only a limited autoantlbody production, and responding T cells were not stimulated by APC pulsed with intact snlKNPs in vitro. Coimmunization and boosting of normal mice with a mixture of native snlKNPs and cryptic pepndes, however, induced spreading of the anti-snRNP antibody response. The diversification of the autoimmune response towards snRNPs (4) presumably occurs through selective uptake of the exogenous snlkNPs by different autoreactive B ceils that then present processed snlKNP antigen to T cells that recognize newly revealed cryptic peptides. In the experimental autoimmunity we have described here, the &versification of the autoimmune response occurred without the need for any challenge with exogenous intact La/Ro 1KNPs suggesting that the autoimmunization driving the spreadmg of the response was caused by endogenous turnover ofintracellular RNPs.
We propose that under normal conditions, subdominant self-determinants are continuously being presented to T cells by APC, including self-reacnve B cells (44) , but this presentanon is qualitatively (45) and quantitatively (46) insufficient to prime naive self-reactive T cells. In particular, the necessary costimulatory signals are likely to be absent under conditions of constitutive antigen presentation, and the density of subdominant determinants presented on the surface of the APC probably falls below the threshold for activation of naive T cells.
It seems likely that experimentally induced autoimmunity to the La/Iko RNP occurs because immunization overcomes the priming threshold by using larger amounts of antigen than is normally encountered in vivo and by using adjuvants to activate APC and induce the qualitative costimulatory APC functions that are necessary for T cell priming (45, (47) (48) (49) (50) (51) (52) . In other words, experimental induction of autoimmunity exposes the extent of immune selfignorance.
Experimental autoimmunity to autologous recombinant La (6) and iKo 52-kD antigen (53) can be induced by immunization with recombinant autologous La protein (6), whereas immunization with autologous nanve snRNPs (1, 4) , cytochrome c (17, 18, 54) , histone preparations (6, 55) , nDNA (56) , and P53 antigen (57) all fail to induce high titer autoantibody responses in experimental animals. These &fferences in the immunogeniclty of lntracellular self-antigens might reflect degrees of host immune tolerance based on antigen abundance, turnover, adjuvanticity, intracellular trafficking, or structural complexity affecting antigen processing. Alternatively, the use of recombinant intact La antigen may facilitate its processing compared with native La antigen. Notably, the recombinant La was haghly soluble and retained the capacity to bind poly U 1KNA (30), ATP, patient autoantibodies, and mouse anti-La mAbs, suggesting that some native structure is maintained by the bacterial La antigen. Nonetheless, it remains possible that challenge wath native La/tLo 1KNP antigens may result in a hierarchy of peptide determinants different from that observed with recombinant proteins. However, this does not alter the evidence that immunization with peptide determinants nominally defined as subdominant resulted in a natural spreading of autoimmunity to involve multiple components of the La/1Ko 1KNP.
We propose that the initial diverslficanon of the autoimmune response is driven by selective constitutive uptake of endogenous "native" La/1Ko tLNP complexes by autoreactive B cells expressing specific mIg (44) leading to presentation of the same subdominant determinants after antigen processing. Thus, T cells specific for one subdominant determinant might provide helper signals to distinct autoreacrive B cells with differing specificities within the IKNP complex. It is also possible that once the autoimmune response is initiated, natural presentation of mulnple subdominant (or cryptic) determinants will lead to spreading of the T cell response (7) . Spreading of T cell autmmmunity may depend on priming by specific autoreactive B cells (54) , but could also involve enhanced antigen presentation through FclK uptake of autoantibody-autoantigen complexes. The relative contribution of these potennal mechanisms in explaining diversificanon of the autoimmune response needs clarification. If systemic autoimmunity involving ubiqmtous self-antigens is initiated by T cell responses to one or two subdominant self peptides, then selecnve antigen presentation might explain HLA class II allele association with certain antinuclear autoantibodies (58) . Maintenance of autmmmunity may reqmre chronic exposure to an antigenic trigger as well as a genetic predisposition affecting funcnons such as MHC restriction of non-tolerogenic determinants (59) , defective immune clearance, or exaggerated cytokine production (60) . Notwithstanding these considerations, the mechanism by which particular sets of nuclear autoantigens are selected in different systemic autoimmune disorders remains mysterious. Our observation here, which has shown that complex patterns of autoantibody production can be triggered by immunity to a single peptide determinant, suggests how limited molecular mimicry by exogenous agents might initiate spreading of the autoimmune response (61) .
